Date published: 2025-12-28

1-800-457-3801

SCBT Portrait Logo
Seach Input

PISSLRE Inhibitors

Chemical inhibitors of PISSLRE can exert their inhibitory effects through various mechanisms that impede the kinase activity of the protein. Staurosporine, for example, is a potent non-selective inhibitor of protein kinases, including members of the cyclin-dependent kinase (CDK) family to which PISSLRE belongs. By inhibiting CDKs, Staurosporine directly reduces the kinase activity of PISSLRE. Similarly, Roscovitine targets CDKs by selectively inhibiting their activity, which leads to a reduction in PISSLRE's ability to phosphorylate substrates. Olomoucine and Purvalanol A also bind to the ATP pocket of CDKs, preventing ATP from binding and thus inhibiting the phosphorylation activity of PISSLRE. Flavopiridol operates through competitive inhibition at the nucleotide-binding site, which blocks PISSLRE's access to ATP, necessary for its kinase function.

Alsterpaullone and Butyrolactone I both target CDKs, with Alsterpaullone competing with ATP for binding to the kinase domain, thus preventing PISSLRE from carrying out its kinase activity. Butyrolactone I, while being particularly selective for CDK2, also indirectly affects the activity of PISSLRE by inhibiting the phosphorylation events that PISSLRE would typically facilitate. Indirubin-3'-monoxime works by allosterically altering the kinase domain of CDKs, affecting the ability of PISSLRE to phosphorylate its substrates. Dinaciclib, AZD5438, and R547 are all strong inhibitors of multiple CDKs, which in turn decreases the kinase activity of PISSLRE. By inhibiting these kinases, these chemicals reduce the capacity of PISSLRE to add phosphate groups to its target proteins. Lastly, SNS-032, with its selectivity for CDKs such as CDK2, CDK7, and CDK9, impedes the kinase activity of PISSLRE, affecting the protein's role in cell cycle progression and signal transduction due to reduced substrate phosphorylation. Each of these chemicals disrupts the kinase activity of PISSLRE by targeting the ATP binding site, altering the kinase domain, or inhibiting the activity of closely related CDKs necessary for PISSLRE functionality.

SEE ALSO...

Items 691 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING